A Phase II Study of Alemtuzumab and Pentostatin In T-Cell Neoplasms.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2012
At a glance
- Drugs Alemtuzumab; Pentostatin
- Indications T cell lymphoma
- Focus Therapeutic Use
- 16 Mar 2010 Actual patient number (26) added as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 16 Mar 2010 Planned end date changed from 1 Feb 2011 to 1 Mar 2010 as reported by ClinicalTrials.gov.